Skip to main content
Skip to section navigation
Skip to footer
Investors
Overview
News & Events
Overview
Press Releases
In The News
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
In The News
Investors
Investors
Overview
News & Events
Overview
Press Releases
In The News
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
July 16, 2019
Dietrich Stephan On The New Nasdaq Stock NBSE
July 10, 2019
Pittsburgh's newest public company could debut next week
June 10, 2019
Platform plays offer opportunity, potential pitfalls
March 22, 2019
Interview with the CEO: NeuBase Therapeutics, Inc. (NASDAQ:NBSE)
March 22, 2019
Targeting Repeat Expansion Disorders with Next-Gen Antisense Drugs
March 11, 2019
NeuBase Therapeutics announces $9M financing agreement
January 11, 2019
JPM19: How Little Fish in the Big Ocean Get Noticed Without Being Eaten by Sharks
January 10, 2019
For tiny biotechs, J.P. Morgan is a big opportunity — and a big cost
January 5, 2019
Biotech kicks off the year with conferences in San Francisco
January 4, 2019
LifeX's NeuBase Therapeutics is acquired by Ohr Pharmaceutical
rss_feed
RSS
arrow_back
1
2
3
arrow_forward
Email Alerts
Contacts
RSS News Feed